Active Pharmaceutical Ingredient (API)
Pioglitazone Hydrochloride
Insulin Sensitizer (Thiazolidinedione)
A thiazolidinedione (TZD) used to improve glycemic control in Type 2 Diabetes. It acts as an insulin sensitizer by activating PPAR$\gamma$ receptors, which modifies gene expression and improves the body's response to insulin. While effective, its use is associated with a risk of fluid retention and potential increase in heart failure risk.
Technical Profile
- Reference Code
- PIO046
- CAS Number
- 112529-15-4
- Chemical Class
- N/A
- Therapeutic Class
- N/A
Verified Brands
Medicines containing Pioglitazone Hydrochloride as an active ingredient.
| Brand Name | Manufacturer | Formulation | MRP | |
|---|---|---|---|---|
| Pioz 15 G | USV Private Limited | Tablet (15 mg) | ₹62.00 | View Details |
| Cetapin P 15 H | Sanofi India Ltd | Tablet (15 mg) | ₹84.00 | View Details |
| Pioz MF 15 H | USV Private Limited | Tablet (15 mg) | ₹72.50 | View Details |
| Alsita MP 1000 G | Alkem Laboratories Ltd | Tablet (15 mg) | ₹245.00 | View Details |
| Epride-GP2 G | Zenstar Life Sciences (Elkos) | Tablet (15 mg) | ₹105.00 | View Details |